Nasdaq · CIK 0001830487
PHVS Pharvaris N.V.
Insider trading from SEC Form 4. Last filing 18 d ago. Close $31.10 on Oct 9, 2026, +48% from the 52-week low and -20% from the high.
In brief
Pharvaris N.V. (PHVS) has 55 SEC Form 4 filings on file from 11 insiders, the latest filed on Sep 25, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 18 open-market sells worth $20M, net -$20M.
43 open-market trades have been scored at PHVS. The newest: Viviane Monges (director) sold $396k of stock on Sep 23, 2026, filed Sep 25, 2026, scored 51 (moderate). The largest of the 43 shown: Johannes Gerardus Christiaan Petrus Schikan (director) sold $7.0M on Sep 17, 2026, scored 75 (notable). 10 insiders sold within 14 days of each other around Sep 23, 2026.
25 Form 144 notices of planned sales are on file, the latest filed Sep 23, 2026.
Last 90 days
Net insider value
-$20M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
18
$20M by 10 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
PHVSOct 9, 2026 · close 31.10
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Pharvaris N.V., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Viviane Monges director sell | $396k 11,969 shares | -69% | - | |
| 20Weak | Johannes Gerardus Christiaan Petrus Schikan director sell | $29k 800 shares | -1% | - | |
| 49Moderate | David W. Nassif CFO / CLO sell | $219k 6,000 shares | -5% | - | |
| 60Notable | Elisabeth Bjork director sell | $2.0M 52,500 shares | -78% | - | |
| 34Weak | Robert Glassman director sell | $559k 14,493 shares | -58% | - | |
| 57Moderate | Anne Lesage Chief Early Development sell | $765k 20,000 shares | -21% | - | |
| 65Notable | Peng Lu President sell | $3.5M 100,000 shares | -61% | - | |
| 75Notable | Johannes Gerardus Christiaan Petrus Schikan director sell | $7.0M 200,000 shares | -63% | - | |
| 60Notable | Stefan Andreas Abele Chief Technical Ops Officer sell | $1.8M 46,400 shares | -54% | - | |
| 20Weak | Robert Glassman director sell | $332k 8,667 shares | -45% | - | |
| 30Weak | Wim Souverijns Chief Commercial Officer sell | $1.0M 26,090 shares | -40% | - | |
| 24Weak | Peng Lu President sell | $602k 15,000 shares | -19% | - | |
| 29Weak | Berndt Modig Chief Executive Officer sell | $90k 2,291 shares | -2% | - | |
| 30Weak | Anne Lesage Chief Early Development sell | $1.1M 30,000 shares | -35% | - | |
| 19Weak | Robert Glassman director sell | $300k 8,000 shares | -43% | - | |
| 25Weak | Peng Lu President sell | $610k 15,000 shares | -19% | - | |
| 14Weak | Berndt Modig Chief Executive Officer sell | $80k 2,292 shares | -2% | +68% from low-4% from high | |
| 29Weak | Berndt Modig Chief Executive Officer sell | $80k 2,292 shares | -2% | +79% from low-2% from high | |
| 40Moderate | Anne Lesage Chief Early Development sell | $2.7M 76,172 shares | -130% | +101% from low0% from high | |
| 40Moderate | Johannes Gerardus Christiaan Petrus Schikan director sell | $1.3M 37,600 shares | -11% | +101% from low0% from high | |
| 6Weak | Anne Lesage Chief Early Development sell | $162k 4,600 shares | -8% | +96% from low-0% from high | |
| 30Weak | Peng Lu Chief Medical Officer sell | $1.0M 29,700 shares | -37% | +96% from low-0% from high | |
| 19Weak | Johannes Gerardus Christiaan Petrus Schikan director sell | $84k 2,400 shares | -1% | +101% from low0% from high | |
| 0Weak | Peng Lu Chief Medical Officer sell | $10k 300 shares | -0% | +97% from low-2% from high | |
| 28Weak | Berndt Modig Chief Executive Officer sell | $71k 2,291 shares | -2% | +90% from low-4% from high | |
| 39Weak | Anna Nijdam Principal Accounting Officer sell | $82k 2,670 shares | -5% | +97% from low-4% from high | |
| 64Notable | Viviane Monges director sell | $293k 9,667 shares | -64% | +98% from low-7% from high | |
| 51Moderate | David W. Nassif CFO / CLO sell | $303k 10,000 shares | -8% | +98% from low-7% from high | |
| 33Weak | Anna Nijdam Principal Accounting Officer sell | $225k 7,330 shares | -14% | +98% from low-7% from high | |
| 19Weak | Elisabeth Bjork director sell | $293k 10,000 shares | -40% | +90% from low-11% from high | |
| 28Weak | Berndt Modig Chief Executive Officer sell | $67k 2,292 shares | -2% | +86% from low-13% from high | |
| 48Moderate | Stefan Andreas Abele Chief Technical Ops Officer sell | $261k 8,748 shares | -20% | +97% from low-8% from high | |
| 39Weak | Robert Glassman director sell | $298k 10,000 shares | -49% | +97% from low-8% from high | |
| 29Weak | Wim Souverijns Chief Commercial Officer sell | $299k 10,000 shares | -18% | +97% from low-8% from high | |
| 17Weak | Peng Lu Chief Medical Officer sell | $427k 14,166 shares | -18% | +90% from low-5% from high | |
| 40Moderate | Anne Lesage Chief Early Development sell | $1.5M 48,300 shares | -80% | +93% from low-1% from high | |
| 24Weak | Peng Lu Chief Medical Officer sell | $566k 18,733 shares | -28% | +93% from low-1% from high | |
| 35Weak | Johannes Gerardus Christiaan Petrus Schikan director sell | $997k 32,900 shares | -8% | +93% from low-1% from high | |
| 22Weak | Anne Lesage Chief Early Development sell | $442k 14,700 shares | -26% | +103% from low0% from high | |
| 7Weak | Peng Lu Chief Medical Officer sell | $213k 7,101 shares | -10% | +103% from low0% from high | |
| 22Weak | Johannes Gerardus Christiaan Petrus Schikan director sell | $213k 7,100 shares | -2% | +103% from low0% from high | |
| 28Weak | Berndt Modig Chief Executive Officer sell | $66k 2,292 shares | -2% | +110% from low-2% from high | |
| 45Moderate | Berndt Modig Chief Executive Officer sell | $647k 23,333 shares | -14% | +127% from low-8% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 23, 2026 | VIVIANE ROSINE FRANCOISE BECK MONGES Director | 11,969 0.02% of outstanding | $396k | Sep 23, 2026 | none |
| Sep 22, 2026 | JOHANNES GER. CHRIS. PE SCHIKAN Director | 800 0.00% of outstanding | $29k | Sep 22, 2026 | $8.4M |
| Sep 21, 2026 | DAVID NASSIF Officer | 6,000 0.01% of outstanding | $219k | Sep 21, 2026 | none |
| Sep 17, 2026 | ELISABETH E. BJORK Director | 52,500 0.07% of outstanding | $2.0M | Sep 17, 2026 | none |
| Sep 17, 2026 | ROBERT GLASSMAN Director | 14,493 0.02% of outstanding | $559k | Sep 17, 2026 | $632k |
| Sep 17, 2026 | GRAYMATTERS CONSULTING Officer | 20,000 0.03% of outstanding | $765k | Sep 17, 2026 | $3.9M |
| Sep 17, 2026 | PENG LU Officer | 100,000 0.15% of outstanding | $3.5M | Sep 17, 2026 | $2.2M |
| Sep 17, 2026 | SCHOODIC MANAGEMENT BV Officer, Director | 300,000 0.46% of outstanding | $11M | Sep 17, 2026 | $250k |
| Sep 17, 2026 | JOHANNES GER. CHRIS. PE SCHIKAN Officer, Director | 200,000 0.31% of outstanding | $7.0M | Sep 17, 2026 | $1.4M |
| Sep 15, 2026 | STEFAN ABELE Officer | 46,400 0.07% of outstanding | $1.8M | Sep 15, 2026 | none |
| Sep 15, 2026 | ROBERT GLASSMAN Director | 8,667 0.01% of outstanding | $332k | Sep 15, 2026 | $300k |
| Sep 14, 2026 | Berndt B.A,E. Modig Director, Officer | 2,291 0.00% of outstanding | $87k | Sep 14, 2026 | $231k |
| Sep 14, 2026 | WIM SOUVERIJNS Officer | 26,090 0.04% of outstanding | $1.0M | Sep 14, 2026 | none |
| Sep 10, 2026 | ANNE LESAGE Officer | 30,000 0.04% of outstanding | $1.1M | Sep 10, 2026 | $2.8M |
| Sep 9, 2026 | ROBERT R. GLASSMAN Director | 8,000 0.01% of outstanding | $300k | Sep 9, 2026 | none |
| Sep 8, 2026 | PENG LU Officer | 30,000 0.04% of outstanding | $1.1M | Sep 8, 2026 | $1.0M |
| Aug 14, 2026 | Berndt B.A,E. Modig Director, Officer | 2,292 0.00% of outstanding | $78k | Aug 14, 2026 | $220k |
| Jul 13, 2026 | Berndt B.A,E. Modig Director, Officer | 2,292 0.00% of outstanding | $80k | Jul 13, 2026 | $205k |
| Jun 30, 2026 | ANNE SIMONNE J. LESAGE Officer | 27,872 0.04% of outstanding | $967k | Jun 30, 2026 | $2.6M |
| Jun 30, 2026 | GrayMatters Consulting B.V. Officer | 30,703 0.05% of outstanding | $1.1M | Jun 30, 2026 | $2.6M |
| Jun 30, 2026 | Hans H. Schikan Director | 30,712 0.05% of outstanding | $1.1M | Jun 30, 2026 | $1.5M |
| Jun 29, 2026 | ANNE SIMONNE J. LESAGE Officer | 8,300 0.01% of outstanding | $282k | Jun 29, 2026 | $2.1M |
| Jun 29, 2026 | GrayMatters Consulting B.V. Officer | 6,997 0.01% of outstanding | $238k | Jun 29, 2026 | $2.1M |
| Jun 29, 2026 | Hans H. Schikan Director | 6,888 0.01% of outstanding | $234k | Jun 29, 2026 | $1.3M |
| Jun 26, 2026 | PENG LU Officer | 14,700 0.02% of outstanding | $490k | Jun 26, 2026 | $1.7M |
Transactions
The newest 50 of 166 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Viviane Monges director | MOption exercise Common Stock | +11,969 | $8.05 | $96k | 17,469 | 18 d ago |
| Sep 23, 2026 | Viviane Monges director | SOpen-market sale Common Stock | -11,969 | $33.05 | $396k | 5,500 | 18 d ago |
| Sep 23, 2026 | Viviane Monges director | MOption exercise Stock Option (Right to Buy)derivative | -11,969 | $0.00 | $0 | 9,031 | 18 d ago |
| Sep 22, 2026 | Peng Lu President | MOption exercise Common Stock | +45,308 | $2.59 | $117k | 110,261 | 19 d ago |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan director | MOption exercise Common Stock | +800 | $20.00 | $16k | 115,967 | 19 d ago |
| Sep 22, 2026 | Peng Lu President | MOption exercise Stock Option (Right to Buy)derivative | -45,308 | $0.00 | $0 | 0 | 19 d ago |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan director | SOpen-market sale Common Stock | -800 | $36.19 | $29k | 115,167 | 19 d ago |
| Sep 22, 2026 | Johannes Gerardus Christiaan Petrus Schikan director | MOption exercise Stock Option (Right to Buy)derivative | -800 | $0.00 | $0 | 34,200 | 19 d ago |
| Sep 21, 2026 | David W. Nassif CFO / CLO | SOpen-market sale Common Stock | -6,000 | $36.47 | $219k | 114,300 | 20 d ago |
| Sep 21, 2026 | David W. Nassif CFO / CLO | GGift Common Stock | -500 | $0.00 | $0 | 113,800 | 20 d ago |
| Sep 17, 2026 | Robert Glassman director | MOption exercise Common Stock10b5-1 | +14,493 | $18.14 | $263k | 24,993 | 22 d ago |
| Sep 17, 2026 | Anne Lesage Chief Early Development | SOpen-market sale Common Stockindirect: By GrayMatters Consulting BVBA | -20,000 | $38.27 | $765k | 73,969 | 22 d ago |
| Sep 17, 2026 | Peng Lu President | MOption exercise Common Stock | +100,000 | $2.59 | $259k | 164,953 | 22 d ago |
| Sep 17, 2026 | Elisabeth Bjork director | MOption exercise Common Stock | +35,000 | $14.39 | $504k | 50,167 | 22 d ago |
| Sep 17, 2026 | Johannes Gerardus Christiaan Petrus Schikan director | SOpen-market sale Common Stock | -200,000 | $35.00 | $7.0M | 115,167 | 22 d ago |
| Sep 17, 2026 | Berndt Modig Chief Executive Officer | MOption exercise Common Stockindirect: By Schoodic Management BV | -300,000 | $35.00 | $11M | 650,000 | 22 d ago |
| Sep 17, 2026 | Robert Glassman director | SOpen-market sale Common Stock10b5-1 | -14,493 | $38.56 | $559k | 10,500 | 22 d ago |
| Sep 17, 2026 | Peng Lu President | SOpen-market sale Common Stock | -100,000 | $35.00 | $3.5M | 64,953 | 22 d ago |
| Sep 17, 2026 | Elisabeth Bjork director | MOption exercise Common Stock | +17,500 | $18.14 | $317k | 67,667 | 22 d ago |
| Sep 17, 2026 | Robert Glassman director | MOption exercise Stock Option (Right to Buy)derivative | -14,493 | $0.00 | $0 | 0 | 22 d ago |
| Sep 17, 2026 | Peng Lu President | MOption exercise Stock Option (Right to Buy)derivative | -13,308 | $0.00 | $0 | 0 | 22 d ago |
| Sep 17, 2026 | Elisabeth Bjork director | SOpen-market sale Common Stock | -52,500 | $37.89 | $2.0M | 15,167 | 22 d ago |
| Sep 17, 2026 | Peng Lu President | MOption exercise Stock Option (Right to Buy)derivative | -86,692 | $0.00 | $0 | 45,308 | 22 d ago |
| Sep 17, 2026 | Elisabeth Bjork director | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 0 | 22 d ago |
| Sep 17, 2026 | Elisabeth Bjork director | MOption exercise Stock Option (Right to Buy)derivative | -17,500 | $0.00 | $0 | 0 | 22 d ago |
| Sep 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | MOption exercise Common Stock | +45,000 | $16.40 | $738k | 85,468 | 26 d ago |
| Sep 15, 2026 | Robert Glassman director | MOption exercise Common Stock10b5-1 | +8,667 | $22.31 | $193k | 19,167 | 26 d ago |
| Sep 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | SOpen-market sale Common Stock | -45,000 | $38.14 | $1.7M | 40,468 | 26 d ago |
| Sep 15, 2026 | Robert Glassman director | SOpen-market sale Common Stock10b5-1 | -8,667 | $38.27 | $332k | 10,500 | 26 d ago |
| Sep 15, 2026 | Robert Glassman director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,667 | $0.00 | $0 | 0 | 26 d ago |
| Sep 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | SOpen-market sale Common Stock | -1,400 | $39.24 | $55k | 39,068 | 26 d ago |
| Sep 15, 2026 | Stefan Andreas Abele Chief Technical Ops Officer | MOption exercise Stock Option (Right to Buy)derivative | -45,000 | $0.00 | $0 | 44,500 | 26 d ago |
| Sep 14, 2026 | Wim Souverijns Chief Commercial Officer | MOption exercise Common Stock10b5-1 | +20,000 | $17.43 | $349k | 65,111 | 27 d ago |
| Sep 14, 2026 | Wim Souverijns Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -20,000 | $39.31 | $786k | 45,111 | 27 d ago |
| Sep 15, 2026 | Wim Souverijns Chief Commercial Officer | SOpen-market sale Common Stock10b5-1 | -6,090 | $38.99 | $237k | 39,021 | 27 d ago |
| Sep 14, 2026 | Wim Souverijns Chief Commercial Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 95,000 | 27 d ago |
| Sep 14, 2026 | Berndt Modig Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,291 | $39.40 | $90k | 128,334 | 28 d ago |
| Sep 11, 2026 | Peng Lu President | MOption exercise Common Stock10b5-1 | +15,000 | $2.59 | $39k | 80,179 | 28 d ago |
| Sep 11, 2026 | Peng Lu President | SOpen-market sale Common Stock10b5-1 | -15,000 | $40.13 | $602k | 65,179 | 28 d ago |
| Sep 11, 2026 | Peng Lu President | FTax withholding Common Stock10b5-1 | -109 | $37.51 | $4,089 | 65,070 | 28 d ago |
| Sep 14, 2026 | Peng Lu President | FTax withholding Common Stock10b5-1 | -117 | $38.02 | $4,448 | 64,953 | 28 d ago |
| Sep 10, 2026 | Anne Lesage Chief Early Development | MOption exercise Common Stock10b5-1 | +30,000 | $8.05 | $242k | 86,450 | 29 d ago |
| Sep 10, 2026 | Anne Lesage Chief Early Development | SOpen-market sale Common Stock10b5-1 | -30,000 | $38.30 | $1.1M | 56,450 | 29 d ago |
| Sep 10, 2026 | Anne Lesage Chief Early Development | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 15,000 | 29 d ago |
| Sep 9, 2026 | Robert Glassman director | MOption exercise Common Stock10b5-1 | +8,000 | $20.00 | $160k | 18,500 | 32 d ago |
| Sep 9, 2026 | Robert Glassman director | SOpen-market sale Common Stock10b5-1 | -8,000 | $37.55 | $300k | 10,500 | 32 d ago |
| Sep 9, 2026 | Robert Glassman director | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,000 | $0.00 | $0 | 0 | 32 d ago |
| Sep 8, 2026 | Peng Lu President | MOption exercise Common Stock10b5-1 | +15,000 | $2.59 | $39k | 80,179 | 34 d ago |
| Sep 8, 2026 | Peng Lu President | SOpen-market sale Common Stock10b5-1 | -15,000 | $40.68 | $610k | 65,179 | 34 d ago |
| Aug 14, 2026 | Berndt Modig Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,292 | $34.77 | $80k | 130,625 | Aug 18, 2026 |
50 of 166 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Stefan Andreas AbeleChief Technical Ops Officer
- Elisabeth Bjorkdirector
- Robert Glassmandirector
- Anne LesageChief Early Development
- Peng LuPresident
- Berndt ModigChief Executive Officer
- Viviane Mongesdirector
- David W. NassifCFO / CLO
- Anna NijdamPrincipal Accounting Officer
- Johannes Gerardus Christiaan Petrus Schikandirector
- Wim SouverijnsChief Commercial Officer
Questions about PHVS
Answered from the filings on this page, as of the latest one.
Are insiders buying PHVS?
As of Sep 25, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 18 open-market sells worth $20M by 10 insiders at Pharvaris N.V. in the last 90 days, net -$20M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade PHVS on the open market?
Viviane Monges (director) sold $396k of PHVS on Sep 23, 2026 and filed the Form 4 on Sep 25, 2026. InsiderTell scored 51 (moderate), with 10 insiders on the same side within 14 days.
How many insiders file Form 4 at Pharvaris N.V.?
11 people have filed a Form 4 at Pharvaris N.V., among them Stefan Andreas Abele (Chief Technical Ops Officer), Elisabeth Bjork (director), Robert Glassman (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.